OHEC 2025 Insights: Technologies to Advance Oman’s Carbon-Free Healthcare Goals

INNERLUXES’ healthcare IT team unpacks the sustainability discussion from OHEC 2025 — the annual Omani national forum that convenes policymakers, providers, and technology leaders to align on collaboration and investment in the healthcare sector. Below, we combine the forum’s key threads with our own delivery experience in healthcare AI, telehealth, and cloud.

If you are planning an actionable IT roadmap that complies with GCC PDPL, national governance policies, and Vision 2040, our healthcare IT consultants are ready to help.

Key Takeaways From the OHEC Discussion: Oman’s Path to Sustainable Healthcare

Smarter care models can bring sustainability as Oman advances its core healthcare goals

In Vision 2040 and the National Health Policy 2025, Oman set clear healthcare goals that include sustainability. Providers want to support those aims, yet their immediate pressure sits elsewhere: staff gaps, access to care outside Muscat, and tight budgets. The conclusion voiced across the forum was pragmatic — healthcare should deliver patient outcomes and care access first, and a lighter carbon footprint will follow as a natural result of smarter care models.

INNERLUXES’ take: When care teams run on thin staffing, it’s better to focus on workload relief than to chase a green badge. For example, providers can set up AI intake and triage with nurse oversight: it clears queues and redirects clinical time to actual care. That same automation trims desk time and lets the same teams serve more patients — which also cuts commute emissions and facility energy spending per case. The energy cost of a single LLM query (say, for intake and triage) is trivial next to the facility and human energy saved on in-person visits, calls, and manual computer work.

The investor perspective at the forum: The patient should always stay at the center of healthcare. Patient outcomes set the benchmark; once that holds, investors look for the same results through a resource-efficient path that respects capital, environmental inputs, and people. The system then sustains performance over time, with a smaller footprint following as a bonus.

Administrative AI and at-home prevention tools bring measurable sustainability gains

Vision 2040 and the Health Policy 2025 outline Oman’s goal of a high-quality, technology-enabled, decentralized healthcare system. The technologies to make this happen sustainably are already within reach.

INNERLUXES’ take: In our experience, four technology options match Oman’s 2040 goals and existing infrastructure:

• AI agents for administrative tasks under nurse governance shorten queues and give staff more patient time.
• Telemedicine brings the clinic to the patient and expands access outside Muscat without building new sites.
• Prevention tools can combine approved national sources, such as Shifa records, with home vitals from RPM kits, patient questionnaires, and outreach results to surface early risk in high-burden cohorts like diabetes.
• Cloud shifts spend to OpEx, so capacity tracks demand and idle hardware fades away — which also lowers the footprint.

The investor perspective at the forum: Post-acute and home care models show strong results: patients continue recovery at home and stay connected with physicians through AI support. That eases bed pressure, limits avoidable returns, and reduces travel, so each case consumes fewer site-based resources and a smaller facility footprint.

What stakeholders can do now to advance sustainability in healthcare

INNERLUXES’ take: Omani providers could begin with telemedicine and AI agents for administrative tasks. These tools need a smaller upfront spend and deliver early gains: shorter queues, steadier care access, and lower routine staff workload. More advanced steps include prevention programs built on Oman’s national digital rails, which help detect chronic risks earlier and reduce the load on hospitals in the long run.

The investor perspective at the forum: Oman’s healthcare community has a chance to shape its own innovation identity. Forums like OHEC offer the space to decide together which technologies deserve priority investment — and to define where the market will create the most value by 2040.

Questions Omani Health Leaders Are Asking After OHEC 2025

These topics dominated the practical conversations around the forum. Here are fuller answers than a session format usually allows.

How do we protect patient data when we adopt AI solutions?

Patient data protection in AI starts with lawful use under Oman’s PDPL and the 2024 Executive Regulations. Every AI use case needs a documented purpose (e.g., intake and triage) approved by a clinical owner, with data fields limited to that purpose. Patients must give explicit consent, and any data use beyond the original AI agent purpose — outreach, model updates — demands a new legal justification, typically extra consent. The Executive Regulations took effect on February 5, 2024, with a compliance grace period to February 5, 2025, so Omani providers can treat these controls as the standard for any pilot starting now.

With the legal footing set, the most common pitfall appears when an AI agent sends prompts with PHI to a vendor LLM running outside the provider’s network. A safe practice includes:

• Keeping the computing processes in local Omani data centers and applying PHI scrubbing before any external model call. An intake and triage agent, for instance, can strip names, MRNs, phone numbers, and policy numbers before sending any prompt to a public LLM.
• Using fixed prompt templates and a list of approved external tools, so the agent talks only to the intended LLM and never leaks patient context by accident.
• Encrypting data in transit and at rest and keeping complete logs.
• Running the LLM endpoint under a contract that prohibits reusing prompts and outputs for model training.

These controls prevent leakage without slowing care — and they prepare teams for scale.

Should providers use de-identified datasets for AI tools?

Truly anonymous data doesn’t fall under PDPL. Pseudonymized data — which keeps coded patient IDs or keys that allow reversal — stays personal and still requires PDPL safeguards and consent. For healthcare AI agents, anonymous data is mostly unsuitable: without patient identifiers, a diabetic care agent can’t link blood sugar measurements for the same person, which makes it impossible to adjust care recommendations. So pseudonymized data is what gets used in most cases, and the real question is how to minimize privacy risks in that setup.

In practice, it means pseudonymized patient data never leaves a controlled environment — a secure data enclave located within Oman. The enclave keeps re-link keys in a separate vault, enforces role-based access and encryption, and logs every AI prompt to meet PDPL requirements.

Here’s how a diabetic care agent can use pseudonymized records stored in an Omani enclave to run tailored patient outreach that supports lifestyle change:

1. The agent compares prompt templates, predesigned for different patient profiles, against real patient patterns — visit frequency, lab results, medication history — and picks the most relevant template for each patient.
2. Only non-personal results leave the enclave for processing by the external LLM: the selected prompt plus a short evaluation summary reflecting its relevance score and earlier engagement performance.
3. The model generates message texts and outreach timing suggestions from this summary, refining tone, specificity, and relevance without storing the data or retraining on it.
4. On receiving the final texts, the enclave securely merges them with patient names and contact details for delivery.

This way, the system stays PDPL-compliant while still delivering personalized communication.

How can we make public-private partnerships (PPP) work to enable tech-enabled care models?

Under Oman’s PPP framework established by Royal Decree 52 of 2019, PPP contracts hinge on measurable service outputs. Consider a public hospital partnering with a private home-health operator for post-discharge recovery. The private partner must meet contract KPIs: first-contact time after discharge, alert response time, avoidable bed-days, and so on. PPP operations software usually becomes the spine of the deal — it ensures seamless patient data exchange through open APIs and FHIR, captures KPIs without manual steps, and provides audit-ready logs so settlement survives disputes.

The joint platform can also route eligibility checks, prior authorization, claims, and remittance through Dhamani. That matters because a PPP inserts a party between the private provider and the insurer: the public body issues a quality acceptance certificate before services can be charged, which slows cash flow. To fix this, the software should link the service event stream to the hospital’s acceptance workflow, flag any missing proof, and push clean utilization and claim events into Dhamani.

The law also expects knowledge transfer. The private home-health partner must hand over its heart-failure escalation playbook, monitoring device kit SOPs for issue and return, the KPI data dictionary with API specs, and more. To support this, the platform should keep a searchable knowledge base with role-based access and one-click exports, so public teams can prove conformance and continue operations at handover without delays.

That’s when a PPP stops draining budgets and starts to free beds, keep cash flow predictable for the private partner, and extend quality care outside Muscat. And care gets more sustainable at the same time, by moving closer to the patient and cutting unnecessary facility time.